Overview

• The Moon Venture led the $7 million round with participation from Pléiade Venture, Plug & Play Ventures, Bpifrance, and AKKA Technologies.
• Funding will support market entry in the United States and United Kingdom, the debut of a patient-facing product focused on pediatric brain cancer and dermatology, and the recruitment of a Chief Medical Officer.
• ArcaScience says its platform combines 24 specialized AI models trained on about 100 billion biomedical data points to speed benefit–risk analysis.
• The company reports early traction with customers including Sanofi, AstraZeneca, GSK, Takeda, ICON, and the Paris Brain Institute, and says its software has supported research involving more than 70,000 patients.
• ArcaScience cites use of its system by the French government during the COVID-19 response, faces competition from vendors such as IQVIA, Parexel, Thermo Fisher, and Prometria, and says it reached break-even twice since late 2024.